Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?

Journal of Hepatology

Volumn 47, Issue 4, 2007, Pages 460-466

  Mazzaferro, Vincenzo ^a   Pulvirenti, Andrea ^a   Coppa, Jorgelina ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 125; ALPHA INTERFERON; ANGIOPEPTIN; DOXORUBICIN; FLUOROURACIL; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

CANCER STAGING; CHEMOEMBOLIZATION; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER SURGERY; LIVER TRANSPLANTATION; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR;

HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEUROENDOCRINE TUMORS; PATIENT SELECTION; PROGNOSIS;

EID: 34548255524     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.07.004     Document Type: Review

References (30)

1. Solcia E., Capella C., Kloppel G., Heitz P.U., Sobin L.H., and Rosai J. Endocrine tumours of the gastrointestinal tract. In: Solcia E., Kloppel G., and Sobin L.H. (Eds). Histologic typing of endocrine tumours. WHO international histological classification of tumours (2000), Springer Verlag, Heidelberg-New York 57-67
2. Blonski W.C., Reddy K.R., Shaked A., Siegelman E., and Metz D.C. Liver transplantation for metastatic neuroendocrine: a case report and review of the literature. World J Gastroenter (2005) 7676-7683
3. Sutcliffe R., Maguire D., Ramage J., Rela M., and Heaton N. Management of neuroendocrine liver metastases. Am J Surg 187 (2004) 39-46
4. Que F.G., Nagorney D.M., Batts K.P., Linz L.J., and Kvols L.K. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 10 (1995) 36-43
5. Martin J.K., Moertel C.G., Adson M.A., and Schutt A.J. Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 118 (1983) 537-542
6. Danforth D.N., Gorden P., and Brennan M.F. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 96 (1984) 1027-1037
7. Norton J.A., Sugarbaker P.H., Doppman J.L., Welsey R.A., Maton P.N., Gardner J.D., et al. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg 203 (1986) 353-359
8. Makridis C., Öberg K., Juhlin C., Rastad J., Johansson H., Lörelius L.E., et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg 14 (1990) 377-386
9. McEntee G.P., Nagorney D.M., Kvols L.K., Moertel C.G., and Grant C.S. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 108 (1990) 1091-1096
10. Søreide O., Berstad T., Bakka A., Schrumpf E., Hanssen L.E., Engh V., et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111 (1992) 48-54
11. Carty S.E., Jensen R.T., and Norton J.A. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112 (1992) 1024-1032
12. Dousset B., Saint-Marc O., Pitre J., Soubrane O., Houssin D., and Chapuis Y. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 20 (1996) 908-915
13. Chen H., Hardacre J.M., Uzar A., Cameron J.L., and Choti M.A. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?. J Am Coll Surg 187 (1998) 88-93
14. Chamberlain R.S., Canes D., Brown K.T., Saltz L., Jarnagin W., Fong Y., et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 190 (2000) 432-445
15. Jaeck D., Oussoultzoglou E., Bachellier P., Lemarque P., Weber J.C., Nakano H., et al. Hepatic metastases of gastropancreatic neuroendocrine tumors: safe hepatic surgery. World J Surg 25 (2001) 689-692
16. Sarmiento J.M., Heywood G., Rubin J., Ilstrup D.M., Nagorney D.M., and Que F.G. Surgical treatment of neuroendocrine metatstases to the liver: a plea for resection to increase survival. J Am Coll Surg 197 (2003) 29-37
17. Yao K.A., Talamonti M.S., Nemcek A., Angelos P., Chrisman H., Skarda J., et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130 (2001) 677-682
18. Makowka L., Tzakis A., Mazzaferro V., Teperman L., Demetris A.J., Iwatsuki S., et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 168 (1989) 107-111
19. Van Vilsteren F.G.I., Baskin-Bey E.S., Nagorney D.M., Sanderson S.O., Kremers W.K., Rosen C.B., et al. Liver transplantation for gastropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl 12 (2006) 448-456
20. Arnold R., Simon B., and Wied M. Treatment of neuroendocrine GEP tumors with somatostatin analogues: a review. Digestion 62 (2000) 84-91
21. Öberg K. Neuroendocrine gastrointestinal tumors. A condense overview of diagnoses and treatment. Ann Oncol 10 (1999) S3-S8
22. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 27 (1998) 1307-1312
23. Le Treut Y., Delpero J., Dousset B., Cherqui D., Segol D., Mantiou G., et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 4 (1997) 355-364
24. Olausson M., Friman S., Cahlin C., Nilsson O., Jansson S., Wangberg B., et al. Indications and results of liver transplantation in patients with neuroendocrine tumors. World J Surg 26 (2002) 998-1004
25. Fernandez J.A., Robles R., Marin C., Hernandez Q., Sanchez Bueno F., Ramirez P., et al. Role of liver transplantation in the management of metastatic neuroendocrine tumors. Transplant Proc 35 (2003) 1832-1833
26. Rosenau J., Bahr M.J., von Wasielewski R., Mengel M., Schmidt H.H., Nashan B., et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 15 (2002) 386-394
27. Cahlin C., Friman S., Ahlman H., Backman L., Mjornstedt L., Lindner P., et al. Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc 35 (2003) 809-810
28. Florman S., Toure B., Kim L., Gondolesi G., Roayaie S., Krieger N., et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 8 (2004) 208-212
29. Arnold R., Trautmann M.E., Creutzfeldt W., Benning R., Benning M., Neuhaus C., et al. Somatostatin analogue octreotide and inhibition of tumor growth in metastatic endocrine gastroenteropancreatic tumors. Gut 38 (1996) 430-438
30. Roskams T., van den Oord J.J., De Vos R., and Desmet V.J. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 137 (1990) 1019-1025